Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


A Prospective Randomised, Double-blinded Cross-over Study to Investigate the Effects of Racemic and S-ketamine on Cerebral Blood Flow on Healthy Volunteers With MRI-ASL


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT01506921

Organisation Name: Lund University

Overal Status: Completed

Start Date: May 2011

Last Update: February 22, 2012

Lead Sponsor: Lund University

Brief Summary: Racemic ketamine and S-ketamine are used in clinical practice today. Little is known of their difference in effect on cerebral blood flow, volume and metabolism. cerebral blood flow (CBF) measuring techniques are limited in time so constant measurement to mirror a dynamic process is impossible or very difficult. A novel MRI application, arterial spin labeling, offers the possibility that without radiation or contrast, to measure semi-continuous CBF with measurements every 60-120 seconds. The investigators will give 14 healthy volunteers both study drugs in a randomised sequence with one week apart and measure regional CBF during the study period of 45 minutes after a sub-anaesthetic bolus dose of 0,6 mg/kg racemic ketamine and 0,3 mg/kg S-ketamine The investigators hypothesize that there is no difference between racemic ketamine and S(+)-ketamine with regards to Arterial Spin Labeling (ASL) measured cerebral blood flow.

Conditions:
  • Healthy
  • Abnormal Vascular Flow


Total execution time in seconds: 0.14759087562561